Weight Loss
Are you facing challenges in shedding those extra pounds?
If you've exhausted every method without success, don't lose hope. Northeast Therapeutics is here to help. Our weight loss programs are designed to provide you with premium solutions proven to facilitate the weight loss results you've been looking for. We use the same GLP-1 ingredient that the brand names advertise, at a fraction of the cost.
Semaglutide
Semaglutide, the same ingredient that is in Ozempic®, Wegovy®, and Rybelsus®, belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. These medications work by mimicking the action of a hormone called GLP-1, which helps regulate blood sugar levels by stimulating insulin release, slowing down stomach emptying, and reducing appetite.
They are typically administered via injection, either once weekly or once daily, depending on the formulation and indication. It has been shown to effectively lower blood sugar levels in people with type 2 diabetes, as well as promote weight loss in individuals with obesity.
In addition to its approved uses in diabetes and obesity, GLP-1 medications are also being investigated for potential benefits in other conditions, such as non-alcoholic steatohepatitis (NASH) and cardiovascular disease.
Tirzepatide
Tirzepatide, the same ingredient that is in Mounjaro® and Zepbound®, is a novel medication that is FDA approved for the treatment of type 2 diabetes mellitus and chronic weight management in adults with obesity. It is a once-weekly injection that works as a dual GLP-1 agonist and GIP agonist to help regulate blood sugar levels and promote weight loss.
Tirzepatide has been shown to be effective in reducing appetite and slowing the movement of food from the stomach into the small intestine, which usually makes people feel full more quickly and for a longer period of time.
Schedule online. It's easy, fast and secure.